Search Results 791-800 of 21375 for anti-TNF drugs

1. Prednisone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Drospirenone And Ethinyl Estradiol (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Gianvi; Loryna; Nikki; Ocella; Syeda ...

3. Calcipotriene (Topical Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Calcitrene; Dovonex; Sorilux. Descriptions.

4. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

   Participation eligibility · Subjects who received anticancer therapy or investigational drug within 28 days of first dose. · Subjects who received any approved ...

5. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

   Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

6. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

   Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...

7. Loteprednol And Tobramycin (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Zylet. Descriptions. Loteprednol and tobramycin ophthalmic ...

8. Cyclopentolate (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Cyclogyl; Cylate; Ocu-Pentolate. Canadian Brand Name.

9. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

   Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...

10. Fighting Parkinson’s Disease and Lewy Body Dementia with Anti-Diabetic Medications to - Mayo Clinic

    Clinical Trials · Fighting Parkinson's Disease and Lewy Body Dementia with Anti-Diabetic Medications to · More about research at Mayo Clinic · Mayo Clinic Footer.